Ignite Creation Date:
2024-05-06 @ 9:04 AM
Last Modification Date:
2024-10-26 @ 12:09 PM
Study NCT ID:
NCT02896023
Status:
UNKNOWN
Last Update Posted:
2019-09-23
First Post:
2016-08-29
Brief Title:
Predictors of Ovarian Reserve in Infertile Women
Sponsor:
Cairo University
Organization:
Cairo University
Study Overview
Official Title:
Sonographic and Laboratory Predictors of Ovarian Reserve in Infertile Women
Status:
UNKNOWN
Status Verified Date:
2019-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients will be subjected to
A Clinical evaluation including history and examination
B Ultrasonographic evaluation of Ovarian Morphometry
Patients will be evaluated in early follicular phase of the menstrual flow cycles days 1-3 by TVS scanning using MINDRAY DP-1100 Plus Digital Machine 75MHz China by only one examiner to avoid inter-observer variations
Ovarian images will be procured in the sagittal and coronal planes and the frozen image reflecting the largest ovarian dimensions will be utilized for the measurement of ovarian length width and height cm as per standard clinical practice Mean values of both ovaries will be used Ovarian volume will be calculated from ellipsoid volume formula Ovarian volume Ovarian Width D1 Ovarian Length D2 Ovarian Height D3 0 523
Antral follicle count will be determined for each patient
C Laboratory Evaluation
Blood samples will be collected in the early follicular phase Samples will be immediately centrifuged and serum saved at -20 degrees for measurement of
Anti Mullerian Hormone AMH
Follicle Stimulating Hormone FSH
Estradiol E2 Using electro-chemiluminescence immunoassay ELICA
A Clinical evaluation including history and examination
B Ultrasonographic evaluation of Ovarian Morphometry
Patients will be evaluated in early follicular phase of the menstrual flow cycles days 1-3 by TVS scanning using MINDRAY DP-1100 Plus Digital Machine 75MHz China by only one examiner to avoid inter-observer variations
Ovarian images will be procured in the sagittal and coronal planes and the frozen image reflecting the largest ovarian dimensions will be utilized for the measurement of ovarian length width and height cm as per standard clinical practice Mean values of both ovaries will be used Ovarian volume will be calculated from ellipsoid volume formula Ovarian volume Ovarian Width D1 Ovarian Length D2 Ovarian Height D3 0 523
Antral follicle count will be determined for each patient
C Laboratory Evaluation
Blood samples will be collected in the early follicular phase Samples will be immediately centrifuged and serum saved at -20 degrees for measurement of
Anti Mullerian Hormone AMH
Follicle Stimulating Hormone FSH
Estradiol E2 Using electro-chemiluminescence immunoassay ELICA
Detailed Description:
Patients will be subjected to
A Clinical evaluation including history and examination
B Ultrasonographic evaluation of Ovarian Morphometry
Patients will be evaluated in early follicular phase of the menstrual flow cycles days 1-3 by TVS scanning using MINDRAY DP-1100 Plus Digital Machine 75MHz China by only one examiner to avoid inter-observer variations
Ovarian images will be procured in the sagittal and coronal planes and the frozen image reflecting the largest ovarian dimensions will be utilized for the measurement of ovarian length width and height cm as per standard clinical practice Mean values of both ovaries will be used Ovarian volume will be calculated from ellipsoid volume formula Ovarian volume Ovarian Width D1 Ovarian Length D2 Ovarian Height D3 0 523
Antral follicle count will be determined for each patient
C Laboratory Evaluation
Blood samples will be collected in the early follicular phase Samples will be immediately centrifuged and serum saved at -20 degrees for measurement of
Anti Mullerian Hormone AMH
Follicle Stimulating Hormone FSH
Estradiol E2 Using electro-chemiluminescence immunoassay ELICA
A Clinical evaluation including history and examination
B Ultrasonographic evaluation of Ovarian Morphometry
Patients will be evaluated in early follicular phase of the menstrual flow cycles days 1-3 by TVS scanning using MINDRAY DP-1100 Plus Digital Machine 75MHz China by only one examiner to avoid inter-observer variations
Ovarian images will be procured in the sagittal and coronal planes and the frozen image reflecting the largest ovarian dimensions will be utilized for the measurement of ovarian length width and height cm as per standard clinical practice Mean values of both ovaries will be used Ovarian volume will be calculated from ellipsoid volume formula Ovarian volume Ovarian Width D1 Ovarian Length D2 Ovarian Height D3 0 523
Antral follicle count will be determined for each patient
C Laboratory Evaluation
Blood samples will be collected in the early follicular phase Samples will be immediately centrifuged and serum saved at -20 degrees for measurement of
Anti Mullerian Hormone AMH
Follicle Stimulating Hormone FSH
Estradiol E2 Using electro-chemiluminescence immunoassay ELICA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None